The Nomination and Remuneration Committee of Renaissance Global Limited approved the allotment of 3,750 equity shares of face value Rs.2 each, fully paid-up, to employees who exercised their vested options under the 'Renaissance Global – Employee Stock Option Scheme 2021' (RGL ESOP 2021). The approval was granted via circular resolution on September 21, 2026.

The equity shares allotted are fully paid-up and shall rank pari passu with the existing equity shares of the company in all respects. The company will apply for listing of these 3,750 equity shares on both the National Stock Exchange of India Limited and BSE Limited.

Consequent to this allotment, the paid-up equity share capital increased from Rs.21,48,07,942 comprising 10,74,03,971 equity shares to Rs.21,48,15,442 comprising 10,74,07,721 equity shares, both at face value of Rs.2 each fully paid-up.

The exercise price per share was Rs.2 with a premium of Rs.108 per share, resulting in total money realized of Rs.4,12,500. The distinctive numbers of the allotted shares range from 10,74,03,972 to 10,74,07,721 (both inclusive), with ISIN number INE722H01024.

ESOP Plan Details:

The RGL ESOP 2021 was approved by shareholders through postal ballot on January 21, 2022. The scheme has multiple grants with different exercise prices:

  • Grants 1, 2, and 3: exercisable @ Rs.110 each
  • Grants 4, 5, 6, and 7: exercisable @ Rs.2 each

Total options granted across all grants: 20,28,702

Vesting details:

  • Grant-1: 6,25,000 options with vesting dates 11/04/2023, 11/04/2024, 11/04/2025, 11/04/2026 (70,000 options cancelled due to resignations)
  • Grant-2: 8,05,000 options with vesting dates 11/04/2023, 11/04/2024, 11/04/2025, 11/04/2026 (40,000 options surrendered/relinquished)
  • Grant-3: 30,000 options with vesting date 06/01/2024 (22,500 options cancelled due to resignation)
  • Grant-4: 3,59,562 options granted but all cancelled due to termination before vesting
  • Grant-5: 51,000 options with vesting date 12/06/2026
  • Grant-6: 1,07,140 options with vesting date 23/01/2026 (53,570 options surrendered/relinquished)

Options can be exercised within 3 years from respective vesting dates. In the current instance, 3,750 options were exercised.

Options lapsed: 98,750 under Grant-1, 2,99,000 under Grant-2, and 53,570 under Grant-6.

Diluted earnings per share pursuant to issue of equity shares on exercise of options is 0.95 per share.

Compliance Information:

The disclosure is made pursuant to Regulation 30 read with Para B of Part A of Schedule III of SEBI Listing Regulations and SEBI Circular dated July 13, 2023. Additional details are provided under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Previous filings were made with BSE (Filing Number: BSE-DCS/IPO/MJ/ESOP-IP/2235/2021-22) and NSE (Filing Number: NSE- NSE/LIST/29860) on January 28, 2022.

No lock-in applies to the allotted shares, and they are identical in all respects to existing shares. No listing fees are payable.